JPMorgan Funds - Thematics - Genetic Therapies C2 (dist) - CHF (hedged)

WKN A2PR31 | ISIN LU2053353749 |  Fonds
Factsheet
03.04.25
74,38 CHF-0,55 % (-0,41)

Fonds

ISIN Name Performance Volatilität Sharpe Ratio
1 LU0637847533 Lacuna Global Health Plus I +12,71 % +11,58 % 0,90
2 LU0247050130 Lacuna Global Health Plus P +12,57 % +11,59 % 0,88
3 LU0695506492 BZ Fine Funds - BZ Fine Pharma A EUR +11,09 % +15,02 % 0,58
4 BE0170812920 KBC Equity Fund Medical Technologies Classic +6,95 % +11,29 % 0,41
5 LU2036817042 CPR Invest - MedTech - A EUR - Dist +4,79 % +12,82 % 0,19
98 LU2053353236 JPMorgan Funds - Thematics - Genetic Therapies A (dist) - EUR (hedged) -20,77 % +21,37 % -1,08
99 LU2053353749 JPMorgan Funds - Thematics - Genetic Therapies C2 (dist) - CHF (hedged) -22,13 % +21,30 % -1,15
100 LU2053353665 JPMorgan Funds - Thematics - Genetic Therapies A (dist) - CHF (hedged) -22,55 % +21,31 % -1,17
101 LU2314628723 JPMorgan Funds - Thematics - Genetic Therapies C (dist) - GBP -22,43 % +19,69 % -1,26
102 LU2015349090 Candriam Equities L Oncology, S-AH - Distribution -14,29 % +12,01 % -1,39